The pharmaceutical preparations turnover in the UK is forecasted to grow steadily from 2024 to 2028. Starting at 19.23 billion Euros in 2024, it is expected to increase to 20.78 billion Euros by 2028. This represents a compound annual growth rate (CAGR) of approximately 1.9% over the five years. The year-on-year growth is modest, with increases ranging from 1.9% to 2.0% each year.
In comparison to the turnover in 2023, which stood at 18.85 billion Euros, there is an evident upward trend. Notably, the turnover is forecasted to grow by 2.0% from 2023 to 2024.
Future trends to watch for include advancements in biotechnology, the impact of new healthcare policies, and the potential disruptions from generic drug introductions. Additionally, the ongoing developments in personalized medicine and the integration of AI in drug development processes could significantly influence the market dynamics.
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
